More

Radiculopathy after a car accident

“Radiculopathy” is often used when there is radiating arm or leg pain with neurological symptoms (pins-and-needles, numbness, weakness) consistent with nerve root involvement. In NSW CTP matters, the common problems are causation (accident vs degeneration) and whether the medical evidence is clear and consistent.

General information only — the right pathway depends on your circumstances.

Common symptoms and signs

  • Radiating pain (arm or leg) in a nerve distribution
  • Pins-and-needles or numbness
  • Weakness (for example grip weakness or foot drop in more severe cases)
  • Pain aggravated by certain movements or positions

Radiculopathy is usually assessed by history + examination, and then supported (or not) by imaging and other testing.

In insurer disputes about capacity, decision-makers usually give more weight to repeated week-by-week function patterns (including medication side effects and rebound) than one isolated “good day” snapshot.

Evidence that commonly matters

  • Early records: where pain started, when radiating symptoms appeared, and any neurological findings.
  • Objective exam findings: reflex changes, strength/sensation changes, positive nerve tension signs.
  • Imaging: MRI findings (disc protrusion, foraminal narrowing) and whether they match the symptoms.
  • Specialist opinion: neurology, neurosurgery or orthopaedics depending on the case.
  • Function + medication side-effect diary: contemporaneous notes on flare/recovery cycles and sedation/cognitive effects can materially strengthen work-capacity evidence.

Common insurer dispute issues

  • Degeneration: insurers may point to pre-existing disc changes.
  • Correlation: whether imaging matches the clinical distribution.
  • Treatment: disputes about injections, surgery, or rehab being “reasonable and necessary”.
  • Capacity: whether restrictions are supported by objective findings.

For more general pathway context, see CTP claim disputes, Personal Injury Commission (PIC) and the WPI threshold framework.

Frequently asked questions

What is radiculopathy (plain English)?
Radiculopathy generally refers to symptoms caused by irritation or compression of a nerve root (often in the neck or lower back), which can cause radiating pain, pins-and-needles, numbness or weakness.
Why do insurers dispute radiculopathy?
Common disputes include whether symptoms are accident-related or due to pre-existing degeneration, whether imaging correlates with clinical signs, and whether treatment is reasonable and necessary.
What evidence usually matters?
Consistent history, objective clinical signs, imaging where relevant, specialist reports, and functional evidence over time (work restrictions, strength/sensation changes).
How can I reduce insurer disputes when imaging is not dramatic?
Keep a disciplined chronology that aligns symptom onset, neurological examination findings, treatment response and practical functional limits. In many radiculopathy disputes, consistent clinical correlation over time is more persuasive than a single scan impression.
Should I run treatment disputes and long-term impairment issues as one argument?
Usually it is safer to structure them as linked but distinct streams: treatment reasonableness/necessity often turns on current function and response-to-care, while permanent impairment issues depend on impairment methodology and timing. Clear stream separation reduces cross-contamination and helps decision-makers stay issue-focused.
If a nerve-root injection helped briefly, can the insurer say I am back to normal work capacity?
A short-lived response does not usually prove stable capacity. It is stronger to document duration of relief, rebound pain, medication side effects, activity limits and failed attempts to sustain normal duties across multiple weeks. Capacity arguments are generally more persuasive when they focus on repeatable function over time, not a single temporary improvement point.
If EMG or nerve-conduction testing is normal, does that end a radiculopathy claim?
Not necessarily. A normal or near-normal study at one point in time does not automatically outweigh consistent clinical findings, symptom distribution, treatment response and documented functional limits. It is usually stronger to explain timing of testing, correlate examination findings and show multi-week function reliability evidence rather than relying on a single test result.
How do I respond if the insurer says reduced physiotherapy attendance means my condition has resolved?
Reduced attendance alone does not reliably prove recovery. It is usually stronger to document practical barriers (cost, travel, flare-ups, wait times), show re-booking continuity, and correlate attendance gaps with dated symptom, medication and function records over several weeks. Decision-makers generally focus on sustained functional reliability, not a single attendance metric.
If surgery is not currently recommended, can the insurer argue my radiculopathy is minor?
Not automatically. A non-surgical plan can still involve substantial pain, neurological symptoms and capacity limits. It is usually stronger to show why surgery is not currently indicated (risk-benefit, clinical thresholds, conservative-path trial), then document objective findings and multi-week function reliability evidence so severity is assessed on real-world impact rather than procedure status alone.
If I can drive short local trips, can the insurer say I can return to normal work?
Usually no. Short, self-paced local driving does not automatically prove you can sustain full work demands. It is stronger to show a 4–6 week reliability record: driving duration limits, pain flare timing after sitting, medication effects, concentration drift, and next-day recovery compared with the actual tasks, pace and safety obligations of your job.
When should I seek coordinated referrals (lawyer + treating specialists + supports)?
Early coordination is usually better when neurological symptoms are affecting work capacity or daily function. A referral pathway can reduce duplicated assessments, tighten evidence chronology and improve consistency before insurer review, IME examinations or PIC escalation.